FDA Inspection 1328694 — Infinite Biomedical Technologies

Infinite Biomedical Technologies — FEI 3004426795

The FDA completed an inspection of Infinite Biomedical Technologies on Jul 30, 2026 in Baltimore, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 30, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Baltimore, MD (United States)

Citations

IDCFRDescription
23068ISO 13485:2016 Clause 6.1(b)Resources for meeting regulatory and customer requirements not provided
23104ISO 13485:2016 Clause 7.3.3Design and development inputs do not include all requirements
23255ISO 13485:2016 Clause 8.5.2Corrective action not taken